Browse Antiviral agents topic

Subtopics (55)

• Adverse and side effects
• Analysis
• Care and treatment
• Case studies
• Cases
• Casualties
• Comparative analysis
• Complications and side effects
• Conferences, meetings and seminars
• Distribution
• Dosage and administration
• Drug testing
• Drug therapy
• Economic aspects
• Evaluation
• Finance
• Forecasts and trends
• Government finance
• Growth
• Health aspects
• Innovations
• Intellectual property
• Investigations
• Labeling
• Laws, regulations and rules
• Licensing agreements
• Licensing, certification and accreditation
• Market research
• Methods
• Models
• Nutritional aspects
• Observations
• Patient outcomes
• Physiological aspects
• Political aspects
• Prices and rates
• Product defects and recalls
• Product development
• Product information
• Product introduction
• Production management
• Reports
• Research
• Risk factors
• Social aspects
• Statistics
• Storage
• Structure-activity relationships
• Study and teaching
• Supply and demand
• Surveys
• Technology application
• Testing
• Training
• Usage

Articles

Title	Author	Type	Date	Words
MicroDose Therapeutx Acquires ViroPharma Portfolio of Investigational Compounds for Treatment of Respiratory Syncytial Virus (RSV).			Nov 9, 2009	688
NanoViricides, Inc. to Present Anti-Influenza Drug Candidate FluCide[TM] Studies at the Influenza Congress 2009.			Nov 9, 2009	744
Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV.			Nov 9, 2009	740
HHS Orders Intravenous Antiviral Flu Medication to Help Patients Hospitalized with 2009 H1N1.			Nov 5, 2009	538
Swine flu drugs can be delivered to rural areas.			Nov 4, 2009	172
SCYNEXIS' SCY-635 Demonstrates Positive Antiviral Activity in Combination with Approved and Investigational Anti-HCV Agents.			Nov 3, 2009	651
United States : Idenix Pharmaceuticals Presents Data On IDX184 For The Treatment Of Hepatitis C Virus (HCV).		Clinical report	Nov 2, 2009	456
Antiviral 'leash' to tame HIV.			Nov 1, 2009	538
BARACLUDE[R] (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis.			Oct 31, 2009	1779
Nutritional Supplements Delay the Progression of AIDS in HIV-Infected Patients not Receiving Antiretroviral Treatment According to the Harold Foster Foundation.			Oct 30, 2009	498
SDI Reports: Antiviral Prescriptions Increase 73% in Past Two Weeks.			Oct 28, 2009	367
Russia: AIDS Healthcare Foundation to Join Three Respected Saint-Petersburg Partners in Innovative New HIV Testing and ARV Treatment Collaboration.			Oct 27, 2009	723
NanoViricides Management Reports that the Company is Fiscally Sound and Its Drug Development Programs are Progressing Successfully.			Oct 26, 2009	1080
Highly active antiretroviral therapy too hard to swallow for HIV patients.			Oct 26, 2009	396
United States : FDA issues emergency use authorization for intravenous antiviral drug peramivir in H1N1 patients.			Oct 24, 2009	286
SDI Reports: Antiviral Prescriptions Increase 36% in 1 Week.			Oct 22, 2009	288
Merck Announces Third-Quarter 2009 Financial Results.			Oct 22, 2009	3928
Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis[TM] HIV Program at the AIDS Vaccine 2009 Conference.		Conference news	Oct 21, 2009	1053
Promising candidates for new HIV drugs found.			Oct 21, 2009	321
New discovery may help create less toxic anti-HIV drugs.			Oct 21, 2009	309
Promising candidates for new HIV drugs found.			Oct 18, 2009	321
New discovery may help create less toxic anti-HIV drugs.			Oct 18, 2009	309
Winn-Dixie Announces Availability of Government-Subsidized Tamiflu and Relenza to Help Under-Insured Customers Battle Flu Season.			Oct 15, 2009	282
Pharmasset, an antiviral drug discovery and development company, has renewed a long term lease for 30,000 s/f of space at 303 College Road East it occupies as headquarters offices at College Park at Princeton Forrestal Center.			Oct 14, 2009	63
PURE Bioscience Expands Business Strategy with Sales and Marketing Alliance for Long-lasting, Broad Spectrum SDC Antimicrobial Products.			Oct 14, 2009	832
United States : FDA Advisory Committee Recommends Approval Of Pfizer's Selzentry For Use In Patients Starting HIV Therapy For The First Time.			Oct 12, 2009	272
Bahrain treats 800 flu patients a day.			Oct 12, 2009	428
Move to curb use of Tamiflu in H1N1 cases.			Oct 11, 2009	316
United states : FDA Advisory Committee Recommends Approval of Pfizer s Selzentry for Use in Patients Starting HIV Therapy for the First Time.			Oct 9, 2009	274
United States : FDA Advisory Committee approves Selzentry tablets for use in patients starting HIV therapy.			Oct 9, 2009	274
United States: Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations.			Oct 9, 2009	442
CytoDyn Transfers Research on Novel AIDS Drug to Massachusetts General Hospital.			Oct 8, 2009	1344
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time.			Oct 8, 2009	943
Pfizer's Selzentry Poised To Be Most Expensive First-Line AIDS Drug.			Oct 8, 2009	509
FDA Marks 100th HIV/AIDS Drug Authorized for Purchase Under PEPFAR.			Oct 6, 2009	700
Avexa Closes ATC's Phase III Trial to Evaluate Data.			Oct 2, 2009	547
UGANDA: MPs pressure government for more AIDS funding.			Oct 1, 2009	442
Don't panic people urged.			Sep 30, 2009	213
Basic hygiene 'more effective against swine flu than drugs'.			Sep 23, 2009	185
NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies.			Sep 21, 2009	1043
Zacks Analyst Blog Highlights: Merck, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and Abbott Labs.			Sep 18, 2009	725
Zimbabwe: NAC buys US$1m worth of ARVs.			Sep 15, 2009	457
Merck's ISENTRESS[R] (raltegravir) Tablets Studied in Comparison to Efavirenz in Combination Therapy Through 96 Weeks in HIV-1 Treatment-Naove Patients.			Sep 13, 2009	8187
'Dung of the devil' plant roots may offer swine flu cure.			Sep 10, 2009	174
NanoViricides, Inc. President Invited to Speak About Rapid Drug Development.			Sep 8, 2009	557
New strategy to combat outbreak.			Sep 8, 2009	408
Uganda: The Disturbing Mystery of Missing HIV/Aids Drugs.			Sep 8, 2009	419
India says no to AIDS drug patents, reaffirms role as 'pharmacy' of poor countries.			Sep 4, 2009	444
AHF Challenges Merck's "Criminal AIDS Drug Pricing" for Isentress.			Sep 3, 2009	858
Cheaper HIV, TB drugs.			Sep 1, 2009	185
Withholding flu drugs from seniors a new discussion item.			Sep 1, 2009	220
ANADYS REPORTS NET LOSS OF $6.5 MILLION 2ND QTR 2009.		Financial report	Sep 1, 2009	1758
ViraCor-IBT Laboratories Launches Comprehensive Influenza and Respiratory Virus Testing Service.			Aug 31, 2009	772
Polymorph Applications: The Mexican Approach.	Snchez-Huerta, Norma		Aug 25, 2009	875
Nanotherapeutics Awarded $30.9 Million NIAID Contract to Develop Inhaled Antiviral for Prophylaxis and Treatment of Smallpox.			Aug 24, 2009	868
Don't give Tamif lu to healthy people.			Aug 23, 2009	415
Uganda: HIV/AIDS Prevention, Care and Treatment Funding Available for Uganda.			Aug 13, 2009	500
United States : Retrovirox receives another NIH grant for novel inhibitors of HIV entry.			Aug 12, 2009	342
Uganda: Global Fund delivers 30 tonnes of HIV/AIDS drugs.			Aug 11, 2009	288
RetroVirox Receives Second NIH Grant to Develop Novel Antivirals.			Aug 11, 2009	388
Oz swine flu death toll rises to 95.			Aug 11, 2009	523
Study warns against Tamiflu side effects on children.			Aug 11, 2009	327
United States : Clinton Foundation Reaches Deal With Matrix, Pfizer To Cut Prices For Second-Line ARVs, TB Drug.			Aug 10, 2009	337
United States : President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries.			Aug 7, 2009	410
President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries.			Aug 6, 2009	1987
H1N1 flu virus has mutated into a form resistant to an antiviral drug.			Aug 4, 2009	281
New antiretroviral drug safe and effective for patients beginning HIV treatment.			Aug 3, 2009	326
HAART may help reduce mother-to-child HIV transmission.			Aug 2, 2009	252
Hypercoagulability due to protein S deficiency in HIV-seropositive patients.	Orlovic, Dragana; Smego, Raymond A.	Report	Aug 1, 2009	2296
AHF Renews Challenge to Merck on Price of AIDS Drug Isentress.			Jul 24, 2009	806
Make Yourself Less Of A Target For Viruses.			Jul 23, 2009	727
ISENTRESSA (raltegravir), from MSD, was as Effective as Efavirenz at.			Jul 22, 2009	819
96-Week MERIT ES Analysis Shows Efficacy Of Pfizer's HIV/AIDS Treatment Celsentri/Selzentry (Maraviroc) In Treatment-Naove HIV Patients; Results Consistent With 48-Week Analysis.			Jul 21, 2009	1249
Merck Announces Second-Quarter 2009 Financial Results.			Jul 21, 2009	3997
'People are creating policy up there, they are not coming down': nurses' views on the expansion of routine provider-initiated HIV testing and counselling in Nairobi, Kenya.	Evans, Catrin; Ndirangu, Eunice	Report	Jun 22, 2009	4416
HIV nursing in Poland.	Daniluk-Kula, Barbara	Essay	Jun 22, 2009	1221
Airport News - Europe.			Jun 15, 2009	953
Destination News - Europe.			Jun 15, 2009	1257
Travel Health Watch.			Jun 15, 2009	595
The limitations of point of care testing for pandemic influenza: what clinicians and public health professionals need to know.	Hatchette, Todd F.	Report	May 1, 2009	3431
Africa must make own AIDS drugs.	Bateman, Chris	Brief article	May 1, 2009	265
Free state--we can't pay for ARV needs.	Bateman, Chris	Brief article	Apr 1, 2009	310
Why the rush to take medication? Issues affecting when clients start medication.	Brazington, Roy		Mar 22, 2009	3130
The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in Alberta.	Sturtevant, Doris; Preiksaitis, Jutta; Singh, Ameeta; Houston, Stan; Gill, John; Predy, Gerry; Fishe	Report	Mar 1, 2009	4139
Late treatment in Africa may disadvantage those with HIV for years.	Alcorn, Keith; Safreed-Harmon, Kelly	Report	Mar 1, 2009	1160
Tanzanians still suffer stigma of HIV, even with universal access to antiretrovirals.	Owur, John	Report	Mar 1, 2009	832
Beating HIV.		Brief article	Feb 1, 2009	173
Government's prison ARV obfuscation 'reprehensible'--Judge.	Bateman, Chris		Feb 1, 2009	445
Children starting antiretrovirals in sub-Saharan Africa have a low risk of death.	Farham, Bridget	Report	Jan 1, 2009	397
Widespread resistance to antiretrovirals among children in the Central African Republic.	Farham, Bridget	Brief article	Jan 1, 2009	328
High early mortality after starting antiretroviral treatment in Africa.		Report	Nov 1, 2008	621
HIV and burns.	Muganza, Adelin	Clinical report	Sep 1, 2008	1369
Body composition can provide valuable information in the management of women with HIV.	Myburgh, Kathryn H.; De Bruto, Petro C.	Report	Jul 1, 2008	3940
Dual drug class resistance in two-thirds of those failing antiretroviral therapy in South Africa.	Farham, Bridget	Report	Jul 1, 2008	581
Arm of international once-daily HIV treatment trial stopped.	Farham, Bridget	Brief article	Jul 1, 2008	226
Prisoners to get HIV drugs.	Bateman, Chris	Brief article	Jul 1, 2008	174
There are many clinically important interactions between HIV and malaria.	Cohen, Cheryl	Report	Jun 1, 2008	2746
Monitor patients before treatment to improve survival in HIV.	Farham, Bridget	Report	Apr 1, 2008	691
Health services given boost to combat AIDS.	Bateman, Chris	Brief article	Apr 1, 2008	168
Review of molecular methods for medical microbiology testing.	Evans, Gloria		Nov 1, 2007	9047